Joel Greenblatt's position in Adma Biologics is currently worth $448 Thousand. That's 0.01% of their equity portfolio (1010th largest holding). The first Adma Biologics trade was made in Q4 2022. Since then Joel Greenblatt bought shares two more times and sold shares on two occasions. The stake costed the investor $238 Thousand, netting the investor a gain of 88% so far.